Cargando…

Usefulness and reliability of cell free fetal DNA screening for main trisomies in case of atypical profile on first trimester maternal serum screening

BACKGROUND: Patients with atypical values of HCG and/or PAPP-A are at higher risk of chromosomal abnormality and vascular complications of pregnancy. The performance of cfDNA in this particular population has not yet been evaluated. OBJECTIVES: The primary objective was to evaluate the usefulness an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carrara, Julie, Vivanti, Alexandre, Jani, Jacques C., Demain, Adèle, Costa, Jean-Marc, Benachi, Alexandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883576/ https://www.ncbi.nlm.nih.gov/pubmed/31779618 http://dx.doi.org/10.1186/s12967-019-02152-7

Ejemplares similares

Autoimmune disorders but not heparin are associated with cell-free fetal DNA test failure
por: Dabi, Yohann, et al.
Publicado: (2018)

Non-Invasive Epigenetic Detection of Fetal Trisomy 21 in First Trimester Maternal Plasma
por: Lim, Ji Hyae, et al.
Publicado: (2011)

Application of an individualized nomogram in first‐trimester screening for trisomy 21
por: Sun, Y., et al.
Publicado: (2021)

A Cost-Effectiveness Analysis of First Trimester Non-Invasive Prenatal Screening for Fetal Trisomies in the United States
por: Walker, Brandon S., et al.
Publicado: (2015)

Evaluation of Maternal Serum sHLA-G Levels for Trisomy 18 Fetuses Screening at Second Trimester
por: Xu, Danping, et al.
Publicado: (2021)

Diagnostic value of maternal alpha-fetoprotein variants in second-trimester biochemical screening for trisomy 21 and 18
por: Chen, Yiming, et al.
Publicado: (2022)

Noninvasive Prenatal Screening for Trisomy 21 in Patients with a Vanishing Twin
por: Kleinfinger, Pascale, et al.
Publicado: (2022)

Biochemical Screening for Fetal Trisomy 21: Pathophysiology of Maternal Serum Markers and Involvement of the Placenta
por: Guibourdenche, Jean, et al.
Publicado: (2023)

Fetal Nasal Bone Status In Iranian Women Undergoing First-Trimester Screening For Trisomy 21: A Review and an Observational Study.
por: Poureisa, Masoud, et al.
Publicado: (2015)

First trimester screening for trisomy 21 in gestational week 8-10 by ADAM12-S as a maternal serum marker
por: Tørring, Niels, et al.
Publicado: (2010)

Performance of second-trimester maternal biochemistry screening (quadruple test vs. triple test) for trisomy 21: An Indian experience
por: Sablok, Aanchal, et al.
Publicado: (2021)

Fetal cystic hygroma in the first trimester led to diagnosis of partial trisomy 22
por: Phupong, Vorapong, et al.
Publicado: (2021)

First trimester diagnosis and screening for fetal aneuploidy
por: Driscoll, Deborah A., et al.
Publicado: (2008)

A new contingent screening strategy increased detection rate of trisomy 21 in the first trimester
por: Luo, Wei, et al.
Publicado: (2023)

Maternal prenatal screening programs that predict trisomy 21, trisomy 18, and neural tube defects in offspring
por: Chen, Yiming, et al.
Publicado: (2023)

Second Trimester Fetal Cardiac Screening – Current Opinion
por: Bravo-Valenzuela, Nathalie Jeanne, et al.
Publicado: (2023)

Impact of Endometrial Preparation on the Maternal and Fetal Cardiovascular Variables of the First Trimester Combined Screening Test
por: Dallagiovanna, Chiara, et al.
Publicado: (2023)

Novel method of real-time PCR-based screening for common fetal trisomies
por: Kim, So Yeon, et al.
Publicado: (2021)

Noninvasive Prenatal Diagnosis of Fetal Trisomy 18 and Trisomy 13 by Maternal Plasma DNA Sequencing
por: Chen, Eric Z., et al.
Publicado: (2011)

Extreme βHCG levels in first trimester screening are risk factors for adverse maternal and fetal outcomes
por: Younesi, Sarang, et al.
Publicado: (2023)

First Trimester Maternal Vitamin D Status and Risks of Preterm Birth and Small-For-Gestational Age
por: Monier, Isabelle, et al.
Publicado: (2019)

Non-Invasive Prenatal Testing of Trisomy 18 by an Epigenetic Marker in First Trimester Maternal Plasma
por: Lee, Da Eun, et al.
Publicado: (2013)

Detection of Embryonic Trisomy 21 in the First Trimester Using Maternal Plasma Cell-Free RNA
por: Weiner, Carl P., et al.
Publicado: (2022)

New cut-off values for screening of trisomy 21, 18 and open neural tube defects (ONTD) during the second trimester in pregnant women with advanced maternal age
por: Chen, Yiming, et al.
Publicado: (2020)

An efficient method for noninvasive prenatal diagnosis of fetal trisomy 13, trisomy 18, and trisomy 21
por: Sun, Xiaohan, et al.
Publicado: (2019)

Maternal Zika Virus Infection in the First Trimester and Fetal Stigmata in the Third Trimester
por: Singh, Divya, et al.
Publicado: (2023)

Normative weight-adjusted models for the median levels of first trimester serum biomarkers for trisomy 21 screening in a specific ethnicity
por: Kor-anantakul, Ounjai, et al.
Publicado: (2017)

Development and Validation of a Deep Learning Model to Screen for Trisomy 21 During the First Trimester From Nuchal Ultrasonographic Images
por: Zhang, Liwen, et al.
Publicado: (2022)

First Trimester Screening Tests Pregnancy and Trisomy 13 Syndrome, Sex Chromosome Aneuploidy in Iran: A Cross-Sectional Study
por: Harfsheno, Mozhgan, et al.
Publicado: (2023)

Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy
por: Sparks, Andrew B, et al.
Publicado: (2012)

The fetal fraction of cell-free DNA in maternal plasma is not affected by a priori risk of fetal trisomy
por: Brar, Herb, et al.
Publicado: (2013)

Patient-friendly integrated first trimester screening by NIPT and fetal anomaly scan
por: Srebniak, Malgorzata Ilona, et al.
Publicado: (2021)

Study on amniotic fluid metabolism in the second trimester of Trisomy 21
por: Liu, Xiaoting, et al.
Publicado: (2019)

DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study
por: Palomaki, Glenn E., et al.
Publicado: (2012)

Comparison of two immunoassay systems for hCGβ and PAPP-A in prenatal screening for trisomy 21, 18, and 13 in the first trimester
por: Engell, Anna Elise, et al.
Publicado: (2017)

MeDIP Real-Time qPCR has the Potential for Noninvasive Prenatal Screening of Fetal Trisomy 21
por: Kazemi, Mohammad, et al.
Publicado: (2017)

Evaluation of first trimester maternal serum inhibin-A for preeclampsia screening
por: Moungmaithong, Sakita, et al.
Publicado: (2023)

Geometric Reliability of Super-Resolution Reconstructed Images from Clinical Fetal MRI in the Second Trimester
por: Ciceri, Tommaso, et al.
Publicado: (2023)

Non-invasive prenatal diagnosis of fetal trisomy 21 using cell-free fetal DNA in maternal blood
por: Lim, Ji Hyae, et al.
Publicado: (2013)

Screening for Preeclampsia and Fetal Growth Restriction in the First Trimester in Women without Chronic Hypertension
por: Tousty, Piotr, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1arq04g4pvdue1pcn55m99ri2v